The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset

BACKGROUND AND PURPOSE: Proton therapy is expected to outperform photon-based treatment regarding organs at risk (OAR) sparing but to date there is no method to practically measure clinical benefit. Here, we introduce the novel ROCOCO Performance Scoring System (RPSS) translating dose differences in...

Descripción completa

Detalles Bibliográficos
Autores principales: in 't Ven, Lieke, Roelofs, Erik, Cubillos Mesías, Macarena, Compter, Inge, Klaver, Yvonne L.B., Smeenk, Robert Jan, Janssens, Geert O., Kaanders, Johannes H.A.M., Fajardo, Raquel Davila, Oldenburger, Foppe, de Ruysscher, Dirk, Troost, Esther G.C., Eekers, Daniëlle B.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966832/
https://www.ncbi.nlm.nih.gov/pubmed/33748441
http://dx.doi.org/10.1016/j.ctro.2021.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966832/
https://www.ncbi.nlm.nih.gov/pubmed/33748441
http://dx.doi.org/10.1016/j.ctro.2021.02.006

Ejemplares similares